RVPH · Reviva Pharmaceuticals Holdings, Inc.
$0.51
+0.01 (+1.09%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of one year after the date the consolidated financial statements are issued. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”View the 10-Q filed Aug 12, 2026
Market Cap
$6.69M
Shares
13.11M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $607,500 |
| Narayan Prabhu | Chief Financial Officer | $404,950 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $2,764,747 |
| Narayan Prabhu | Chief Financial Officer | $1,248,778 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $560,000 |
| Narayan Prabhu | Chief Financial Officer | $412,500 |
| Marc Cantillon | Former Chief Medical Officer | $348,587 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $600,054 |
| Marc Cantillon | Former Chief Medical Officer | $501,981 |
| Narayan Prabhu | Chief Financial Officer | $437,134 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $247,952 |
| Marc Cantillon | Former Chief Medical Officer | $46,042 |
| Narayan Prabhu | Chief Financial Officer | $45,304 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $240,000 |
| Narayan Prabhu | Chief Financial Officer | — |
| Marc Cantillon | Chief Medical Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marc Cantillon | Chief Medical Officer | Resigned | 2022-06-27 |